Home / Various / Gallium (68Ga) Gozetotide
ATC V09IX14 · Other Diagnostic Radiopharmaceuticals for Tumour Detection · updated 2 Nov 2026
Gallium (68Ga) Gozetotide shortage
As of 2 Nov 2026, Gallium (68Ga) Gozetotide has a reported shortage in 1 of the 16 countries we track (Sweden), covering 1 product from 1 company.
Is there a Gallium (68Ga) Gozetotide shortage?
Yes. As of 2 Nov 2026, Gallium (68Ga) Gozetotide is reported short in 1 of the 16 countries we track: Sweden. The earliest expected return is 18 Dec 2026 (Sweden). New since 3 Oct 2026: Sweden.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Novartis NOVN · SIX Swiss
Compared with similar medicines
ATC group V09IX · Other Diagnostic Radiopharmaceuticals for Tumour DetectionAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Locametz 25 mikrogram Injektionsflaska, 1 st | Novartis Europharm Limited | 26 Oct 2026 | 18 Dec 2026 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Gallium (68Ga) Gozetotide shortage?
Yes. As of 2 Nov 2026, Gallium (68Ga) Gozetotide is reported short in 1 of the 16 countries we track: Sweden. The earliest expected return is 18 Dec 2026 (Sweden). New since 3 Oct 2026: Sweden.
When will Gallium (68Ga) Gozetotide be back in stock?
Companies expect supply back from 18 Dec 2026 in Sweden; Sweden: 18 Dec 2026. These are company estimates reported to each authority.
Why is Gallium (68Ga) Gozetotide in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Gallium (68Ga) Gozetotide shortages?
Novartis.